The Sinopharm vaccine is a vaccine developed by China for tackling SARS CoV 2. The vaccine has been developed by Sinopharm, a Chinese state-owned pharmaceutical giant. The vaccine makes use of killed virus, in a manner similar to polio vaccines. It has received emergency use approval in several countries and is at late-stage clinical trials in 10 countries. The vaccine is said to possess 86% effectiveness. Recently, Egypt received its first shipment of the vaccine from China.